CLASIFICATION |
DRUGS |
GENES - rs |
ADVERSE EVENTS |
Nucleoside
Reverse
Transcriptase
Inhibitors |
Zidovudine |
ABCC4 (MRP4)
A1203A - rs11568695 |
Anemia, neutropenia
Fatigue, malaise, headache
Nausea, vomiting
Myalgia, myopathy |
Stavudine |
POLG (Mit DNA)
R964C and E1143G |
Peripheral neuropathy
Pancreatitis
Dyslipidaemia
Diarrhea |
Lamivudine |
ABCC2 (MRP2)
C421A-Q141K - rs2231142
Q126X - rs725522713
V12M - rs2231137
MRP4
3’ UTR - rs3742106 |
Headache, dry mouth |
Abacavir |
HLA-B*5701 - rs3093726
HCP-5 - rs2395029 |
Hypersensitivity syndrome (HSR)
Rash, fever, myalgia, malaise, nausea, vomiting,diarrhea |
Tenofovir |
ABCC4 (MRP4)
K1116K - rs1751034 |
Asthenia
Acute renal insufficiency
Proximal Tubulopathy
Fanconi syndrome |
Non Nucleoside
Reverse
Transcriptase
Inhibitors |
Nevirapine |
ABCB1
I1143I - rs1045642
CYP2B6
Q172H - rs3745274
I328T - rs28399499 |
Hypersensitivity syndrome (HSR)
Skin rash
Elevations in liver function tests, Hepatitis, liver failure |
Efavirenz |
CYP2B6
Q172H - rs3745274
I328T - rs28399499
ABCB1 (MDR1)
I1143I - rs1045642 |
Peripheral Neuropathy |
Protease
Inhibitors |
Atazanavir |
UGT1A1
UGT1A1*28- (rs8175347) |
Hyperbilirubinemia, jaundice
Elevations in liver function tests, PR interval prolongation |
Indinavir |
UGT1A1
UGT1A1*28 - rs8175347
CYP3A4/ CYP3A5
CYP3A4*1B /CYP3A5*1 |
Hyperbilirubinemia, jaundice
Nephrolithiasis, flank pain |
Ritonavir |
ABCA1, APOA5, APOC3, APOE, CETP |
Dyslipidaemia |
Entry Inhibitor |
Maraviroc |
CCR5
Δ32 - rs333 |
Diarrhea, nausea
Upper respiratory tract infections, cough. Joint, muscle pain |